Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- In-licensing
- View
Seeking in licensing opportunities for Europe with a priority for France, Germany and UK for products ready to market in hospitals or under clinical development
LFB is looking for alliances or in-licensing opportunities as the European arm for products ready to market or under clinical development, addressing severe diseases treated in hospitals.
Full description
In-licensed products should address exclusively hospital treated diseases, severe and even rare. The focus is placed on the three therapeutic areas where LFB is a leading actor: immunology, intensive care and haemostasis/coagulation.
Priority is given to therapeutic proteins, recombinant or plasma extracted, monoclonal antibodies and innovative NCE’s.
Development status
Phase III/IV
Type of business relationship sought
LFB is seeking for supply, marketing and distributorship agreements, exclusive for France, semi-exclusive for the rest of Europe.
LFB is ready to consider participation in the local arms of late stage clinical developments.
Licensing contact
Marc Pennacino
Business Development Director
Business Development Director
More information
For more information about the product please visit website.
Company details
LFB SA
LFB is a fully integrated pharmaceutical company exclusively dedicated to therapeutic proteins. LFB has developed a proprietary platform to create and develop highly cytotoxic MAb's
LFB is a fully integrated pharmaceutical company exclusively dedicated to therapeutic proteins. LFB has developed a proprietary platform to create and develop highly cytotoxic MAb's
Related reports
Are you looking for reports related to this particular subject. Our Reports section is the best place to start.
Related items
Related categories
- Industry sector
- Pharmaceutical
- Therapeutic target
- Blood and forming organs
- Hospital and Surgery
- Immune related disorders
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us